BeStock  
Stocks › Biotechnology › RCUS

Arcus Biosciences RCUS

US equityMarket cap rank #2610Biotechnology
$15.62 −$0.16 (-1.01%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.50 -0.77%
Open$15.66
Prev close$15.78
Day range$15.56 – $16.66
Volume1.67M
Market cap$2.25B
P/E (TTM)–
Dividend yield–

RCUS Stock News

Headlines matching Arcus Biosciences or the RCUS ticker, most recent first.

  • Truist Financial Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Announces Target Price $40Market news · 8 Sep 2026 · Direct mention
  • Wedbush Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $43Market news · 30 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $46Market news · 28 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $45Market news · 26 Sep 2026 · Direct mention
  • Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences (RCUS), Prime Medicine, Inc. (PRME) PositiveTipRanks · 25 Sep 2026 · Direct mention
  • TD Cowen Initiates Arcus Biosciences(RCUS.US) With Buy RatingMarket news · 16 Sep 2026 · Direct mention
  • Citi Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $45Market news · 10 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Raises Target Price to $42 PositiveMarket news · 8 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Arcus Biosciences(RCUS.US), With a Forecast Between $42 to $45Market news · 7 Aug 2026 · Direct mention
  • BofA Securities Maintains Arcus Biosciences(RCUS.US) With Hold Rating, Raises Target Price to $29 PositiveMarket news · 3 Aug 2026 · Direct mention
  • Goldman Sachs Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $42Market news · 10 Aug 2026 · Direct mention
  • Wedbush Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $41Market news · 23 Jul 2026 · Direct mention
  • Truist Financial Maintains Arcus Biosciences(RCUS.US) With Buy RatingMarket news · 23 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Raises Target Price to $45 PositiveMarket news · 20 Jul 2026 · Direct mention
  • LifeSci Capital Initiates Arcus Biosciences(RCUS.US) With Buy Rating, Announces Target Price $46Market news · 4 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on RCUS.

Sign in to join the discussion.

Scroll to Top